Vaccine study by Novo Nordisk on Autism

Study was funded by a pharmaceutical company. The Foundation is the primary owner of Novo Nordisk A/S and NovoZymes A/S through its subsidiary company called Novo Holdings A/S. Aside from Novo Nordisk and Novozymes, the foundation is also a major shareholder in more than 75 other companies.